查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1425528

2024 年心臟病診斷全球市場報告

Heart Attack Diagnostic Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，心臟病診斷市場規模一直強勁成長。將從2023年的102.1億美元擴大到2024年的110.7億美元，複合年成長率為8.5%。這段時期的成長歸因於心臟生物標記的發展、心電圖和影像學的引入、診斷通訊協定的標準化、意識、教育舉措以及肌鈣蛋白測試的改進。

2023 年，北美將成為心臟病診斷市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。心臟病診斷市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球心臟病診斷市場促進因素與限制因素
    • 市場驅動力
    • 市場限制
  • 2018-2023年全球心臟病診斷市場規模、表現與成長
  • 全球心臟病診斷市場規模及成長預測，2023-2028、2033

第6章市場區隔

  • 全球心臟病診斷市場，按測試類型、性能和預測細分，2018-2023、2023-2028、2033
  • 心電圖（ECG/EKG）
  • 驗血
  • X光
  • 心臟超音波檢查
  • 冠狀動脈插管術（血管造影術）
  • 運動壓力測試
  • 磁振造影(MRI)
  • 全球心臟病診斷市場，依程序、實際及預測細分，2018-2023、2023-2028、2033
  • 侵入性手術
  • 非侵入性手術
  • 全球心臟病診斷市場，按終端產業細分，實際與預測，2018-2023、2023-2028、2033
  • 醫院
  • 門診手術中心
  • 診斷中心
  • 其他最終用戶

第 7 章 區域與國家分析

  • 全球心臟病診斷市場，按地區、實際和預測，2018-2023、2023-2028、2033
  • 全球心臟病診斷市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 心臟病診斷市場競爭形勢
  • 心臟病診斷市場公司概況
    • Abbott Laboratories
    • F. Hoffmann-La Roche AG
    • General Electric Co.
    • Hitachi Ltd.
    • Koninklijke Philips NV

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章 重大併購

第34章 未來前景與可能性分析

第35章附錄

簡介目錄
Product Code: r12759

Heart Attack Diagnostic Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on heart attack diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for heart attack diagnostic? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The heart attack diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Test Type: Electrocardiogram (ECG/EKG); Blood Tests; X-Ray; Echocardiogram; Coronary Catheterization (Angiogram); Exercise Stress Test; Magnetic Resonance Imaging (MRI)
  • 2) By Procedure: Invasive Procedure; Non-Invasive Procedure
  • 3) By End-Use Industry: Hospitals; Ambulatory Surgical Centers; Diagnostics Centers; Other End-Users
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche AG; General Electric Co.; Hitachi Ltd.; Koninklijke Philips NV
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Heart attack diagnostics encompass methods for identifying, monitoring, screening, and prognosticating to validate the diagnosis of a heart attack. These diagnostics aid in determining the type of heart attack a patient has experienced, facilitating the selection of the most effective treatment. They play a crucial role in diagnosing heart disease.

The primary types of heart attack diagnostic tests include electrocardiogram (ECG/EKG), blood tests, X-ray, echocardiogram, coronary catheterization (angiogram), exercise stress test, and magnetic resonance imaging (MRI). These tests can be conducted through both invasive and non-invasive procedures. An electrocardiogram (ECG) is a rapid test that assesses the heart's electrical activity and rhythm by detecting signals produced during each heartbeat. It is valuable for diagnosing and monitoring heart-related conditions. These heart attack diagnostics are employed in various healthcare settings, including hospitals, ambulatory surgical centers, diagnostic centers, and other end-users.

The heart attack diagnostics market research report is one of a series of new reports from The Business Research Company that provides heart attack diagnostics market statistics, including heart attack diagnostics industry global market size, regional shares, competitors with a heart attack diagnostics market share, detailed heart attack diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the heart attack diagnostics industry. This heart attack diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The heart attack diagnostic market size has grown strongly in recent years. It will grow from $10.21 billion in 2023 to $11.07 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the development of cardiac biomarkers, the introduction of ECG and imaging, the standardization of diagnostic protocols, awareness, and education initiatives, as well as improvements in troponin testing.

The heart attack diagnostic market size is expected to see strong growth in the next few years. It will grow to $15.26 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period can be attributed to factors such as patient empowerment and engagement, the use of data analytics and precision medicine, initiatives in preventive healthcare, ongoing development of healthcare infrastructure, and the adoption of personalized diagnostic approaches. Major trends expected in this period include the implementation of point-of-care testing, the use of high-sensitivity troponin tests, the advancement of non-invasive imaging techniques, the continued progress in personalized medicine, and the increasing use of remote monitoring devices in the healthcare industry.

The heart attack diagnostics market is experiencing substantial growth, driven by the escalating prevalence of cardiac disorders globally. Cardiac disorders, constituting a group of conditions affecting the heart and blood vessels, are exacerbated by lifestyle factors such as unhealthy eating, physical inactivity, tobacco use, and alcohol abuse. Heart attack diagnostics play a pivotal role in analyzing the causes and severity of heart attacks, strokes, and heart failure. According to a 2021 World Health Organization (WHO) study, cardiovascular diseases (CVDs) accounted for 17.9 million deaths worldwide, comprising 32% of total deaths, with 85% attributed to heart attacks and strokes. This alarming rise in cardiovascular diseases, responsible for one-third of global deaths, underscores the continuous growth trajectory of the heart attack diagnostics market.

The heart attack diagnostics market is poised for growth, buoyed by the increasing expenditure in the healthcare sector. Healthcare expenditure, measured as the total cost of healthcare (including public and private spending) as a percentage of GDP, creates an environment conducive to innovation, research, and infrastructure development. This heightened investment contributes to the advancement and expansion of the heart attack diagnostics market. A notable example is the 2021-2030 National Health Expenditure (NHE) report by the Centers for Medicare & Medicaid Services, projecting an annual growth rate of 5.1%, reaching nearly $6.8 trillion by 2030. The anticipated growth in Medicare and Medicaid spending further underscores the significant impact of increased healthcare expenditure on the heart attack diagnostics market.

An influential trend in the heart attack diagnostics market is the development of novel diagnostic techniques, particularly leveraging artificial intelligence (AI). Major players in the market are investing in cutting-edge technologies to enhance heart disease diagnosis. AI, an emulation of human intellect, is being deployed to improve diagnostic radiography, expedite heart problem diagnoses, and enhance stroke treatment. A notable instance is the development of an AI-based method by physician-scientists at Cedars-Sinai's Smidt Heart Institute. This AI program excels in identifying hard-to-diagnose cardiac conditions, effectively predicting accurate diagnoses by recognizing patterns invisible to the human eye. This trend signifies a paradigm shift in heart attack diagnostics, ushering in advanced capabilities for accurate and timely diagnoses.

Major companies in the heart attack diagnostics market are at the forefront of innovation, introducing groundbreaking products such as coronary heart disease detection tests. These tests are designed to identify the presence of coronary heart disease, characterized by the narrowing or blockage of coronary arteries. A notable product in this category is the PrecisionCHD test launched by Cardio Diagnostics Holdings Inc. This blood-based detection method for Coronary Heart Disease (CHD) uniquely integrates epigenetic and genetic biomarkers with Artificial Intelligence (AI). Notably, the PrecisionCHD test provides a rapid and efficient alternative to traditional CHD detection tools, offering convenience with a straightforward blood sample and swift results within 10 business days. This innovation reflects the commitment of major companies to meet evolving customer needs, drive sales, and elevate revenue in the heart attack diagnostics market.

In November 2021, Royal Philips, a leading Netherlands-based multinational conglomerate corporation specializing in health technology, successfully acquired Cardiologs for an undisclosed amount. This strategic acquisition was aimed at enhancing Philips' capabilities in cardiac monitoring and diagnostics. Cardiologs, a France-based medical technology company, is recognized for its innovative use of artificial intelligence (AI) and cloud technology in transforming cardiac diagnostics. The integration of Cardiologs' advanced software technology, electrocardiogram (ECG) analysis, and reporting services into Philips' offerings further solidifies its position in providing cutting-edge solutions in the healthcare sector.

Major companies operating in the heart attack diagnostic market report are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Hitachi Ltd., Koninklijke Philips NV, Midmark Corp., Siemens AG, Toshiba Corp., Welch Allyn Inc., Astrazenca PLC., HILL ROM HOLDINGS Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., Fujifilm Holdings, ACS Diagnostics Inc., Beckman Coulter Inc., Schiller AG, GE Healthcare, HeartFlow, Medtronic PLC, Cardio Diagnostics Holdings Inc., Beckman Coulter Inc., Becton Dickinson and Company, Danaher Corporation, Edwards Lifesciences Corporation, Illumina Inc., Johnson & Johnson, Merck & Co. Inc., Novartis International AG, Pfizer Inc., Quest Diagnostics, Roche Diagnostics, and Thermo Fisher Scientific Inc.

North America was the largest region in the heart attack diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the heart attack diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The heart attack diagnostics market includes revenues earned by entities through tests such as stress tests, cardiac catheterization, cardiac computerized tomography (CT) scan, cardiac magnetic resonance imaging (MRI), and angiogram. The market value includes the value of related goods sold by the service provider or included within the service offering. The heart attack diagnostics market also includes sales of wearable ECG devices, cardiac pacemakers, stents, and ventricular assist devices (VADs) which are used in heart attack diagnostics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Heart Attack Diagnostic Market Characteristics

3. Heart Attack Diagnostic Market Trends And Strategies

4. Heart Attack Diagnostic Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Heart Attack Diagnostic Market Size and Growth

  • 5.1. Global Heart Attack Diagnostic Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Heart Attack Diagnostic Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Heart Attack Diagnostic Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Heart Attack Diagnostic Market Segmentation

  • 6.1. Global Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Electrocardiogram (ECG/EKG)
  • Blood Tests
  • X-Ray
  • Echocardiogram
  • Coronary Catheterization (Angiogram)
  • Exercise Stress Test
  • Magnetic Resonance Imaging (MRI)
  • 6.2. Global Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Invasive Procedure
  • Non-Invasive Procedure
  • 6.3. Global Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostics Centers
  • Other End-Users

7. Heart Attack Diagnostic Market Regional And Country Analysis

  • 7.1. Global Heart Attack Diagnostic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Heart Attack Diagnostic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Heart Attack Diagnostic Market

  • 8.1. Asia-Pacific Heart Attack Diagnostic Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Heart Attack Diagnostic Market

  • 9.1. China Heart Attack Diagnostic Market Overview
  • 9.2. China Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Heart Attack Diagnostic Market

  • 10.1. India Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Heart Attack Diagnostic Market

  • 11.1. Japan Heart Attack Diagnostic Market Overview
  • 11.2. Japan Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Heart Attack Diagnostic Market

  • 12.1. Australia Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Heart Attack Diagnostic Market

  • 13.1. Indonesia Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Heart Attack Diagnostic Market

  • 14.1. South Korea Heart Attack Diagnostic Market Overview
  • 14.2. South Korea Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Heart Attack Diagnostic Market

  • 15.1. Western Europe Heart Attack Diagnostic Market Overview
  • 15.2. Western Europe Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Heart Attack Diagnostic Market

  • 16.1. UK Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Heart Attack Diagnostic Market

  • 17.1. Germany Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Heart Attack Diagnostic Market

  • 18.1. France Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Heart Attack Diagnostic Market

  • 19.1. Italy Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Heart Attack Diagnostic Market

  • 20.1. Spain Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Heart Attack Diagnostic Market

  • 21.1. Eastern Europe Heart Attack Diagnostic Market Overview
  • 21.2. Eastern Europe Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Heart Attack Diagnostic Market

  • 22.1. Russia Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Heart Attack Diagnostic Market

  • 23.1. North America Heart Attack Diagnostic Market Overview
  • 23.2. North America Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Heart Attack Diagnostic Market

  • 24.1. USA Heart Attack Diagnostic Market Overview
  • 24.2. USA Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Heart Attack Diagnostic Market

  • 25.1. Canada Heart Attack Diagnostic Market Overview
  • 25.2. Canada Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Heart Attack Diagnostic Market

  • 26.1. South America Heart Attack Diagnostic Market Overview
  • 26.2. South America Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Heart Attack Diagnostic Market

  • 27.1. Brazil Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Heart Attack Diagnostic Market

  • 28.1. Middle East Heart Attack Diagnostic Market Overview
  • 28.2. Middle East Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Heart Attack Diagnostic Market

  • 29.1. Africa Heart Attack Diagnostic Market Overview
  • 29.2. Africa Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Heart Attack Diagnostic Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Heart Attack Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Heart Attack Diagnostic Market Competitive Landscape
  • 30.2. Heart Attack Diagnostic Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. General Electric Co.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Hitachi Ltd.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Koninklijke Philips NV
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Heart Attack Diagnostic Market Competitive Benchmarking

32. Global Heart Attack Diagnostic Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Heart Attack Diagnostic Market

34. Heart Attack Diagnostic Market Future Outlook and Potential Analysis

  • 34.1 Heart Attack Diagnostic Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Heart Attack Diagnostic Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Heart Attack Diagnostic Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer